Multi-observer contouring of male pelvic anatomy: Highly variable agreement across conventional and emerging structures of interest.


Journal

Journal of medical imaging and radiation oncology
ISSN: 1754-9485
Titre abrégé: J Med Imaging Radiat Oncol
Pays: Australia
ID NLM: 101469340

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 05 06 2018
accepted: 27 11 2018
pubmed: 5 1 2019
medline: 14 8 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

This study quantified inter-observer contouring variations for multiple male pelvic structures, many of which are of emerging relevance for prostate cancer radiotherapy progression and toxicity response studies. Five prostate cancer patient datasets (CT and T2-weighted MR) were distributed to 13 observers for contouring. CT structures contoured included the clinical target volume (CTV), seminal vesicles, rectum, colon, bowel bag, bladder and peri-rectal space (PRS). MR contours included CTV, trigone, membranous urethra, penile bulb, neurovascular bundle and multiple pelvic floor muscles. Contouring variations were assessed using the intraclass correlation coefficient (ICC), Dice similarity coefficient (DSC), and multiple additional metrics. Clinical target volume (CT and MR), bladder, rectum and PRS contours showed excellent inter-observer agreement (median ICC = 0.97; 0.99; 1.00; 0.95; 0.90, DSC = 0.83 ± 0.05; 0.88 ± 0.05; 0.93 ± 0.03; 0.81 ± 0.07; 0.80 ± 0.06, respectively). Seminal vesicle contours were more variable (ICC = 0.75, DSC = 0.73 ± 0.14), while colon and bowel bag contoured volumes were consistent (ICC = 0.97; 0.97), but displayed poor overlap (DSC = 0.58 ± 0.22; 0.67 ± 0.21). Smaller MR structures showed significant inter-observer variations, with poor overlap for trigone, membranous urethra, penile bulb, and left and right neurovascular bundles (DSC = 0.44 ± 0.22; 0.41 ± 0.21; 0.66 ± 0.21; 0.16 ± 0.17; 0.15 ± 0.15). Pelvic floor muscles recorded moderate to strong inter-observer agreement (ICC = 0.50-0.97), although large outlier variations were observed. Inter-observer contouring variation was significant for multiple pelvic structures contoured on MR.

Identifiants

pubmed: 30609205
doi: 10.1111/1754-9485.12844
doi:

Types de publication

Journal Article

Langues

eng

Pagination

264-271

Subventions

Organisme : NHMRC
ID : 1077788

Informations de copyright

© 2019 The Royal Australian and New Zealand College of Radiologists.

Auteurs

Dale Roach (D)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.

Lois C Holloway (LC)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, New South Wales, Australia.

Michael G Jameson (MG)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, New South Wales, Australia.

Jason A Dowling (JA)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Australian e-Health Research Centre, CSIRO, Royal Brisbane Hospital, Brisbane, Queensland, Australia.
School of Mathematical and Physical Sciences, University of Newcastle, Newcastle, New South Wales, Australia.

Angel Kennedy (A)

Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Peter B Greer (PB)

School of Mathematical and Physical Sciences, University of Newcastle, Newcastle, New South Wales, Australia.
Calvary Mater Newcastle Hospital, Newcastle, New South Wales, Australia.

Michele Krawiec (M)

Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Robba Rai (R)

Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia.
Ingham Institute for Applied Medical Research, Sydney, New South Wales, Australia.
Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, New South Wales, Australia.

Jim Denham (J)

School of Medicine and Population Health, University of Newcastle, Newcastle, New South Wales, Australia.

Jeremiah De Leon (J)

Illawarra Cancer Care Centre, Wollongong, New South Wales, Australia.

Karen Lim (K)

Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Megan E Berry (ME)

Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Rohen T White (RT)

Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Sean A Bydder (SA)

Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Hendrick T Tan (HT)

Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

Jeremy D Croker (JD)

Fiona Stanley Hospital, Perth, Western Australia, Australia.

Alycea McGrath (A)

Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.

John Matthews (J)

Radiation Oncology, Auckland City Hospital, Auckland, New Zealand.

Robert J Smeenk (RJ)

Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Martin A Ebert (MA)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, New South Wales, Australia.
Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
School of Physics and Astrophysics, Faculty of Science, University of Western Australia, Perth, Western Australia, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH